Clinical studies recruiting near Abilene

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Texas Oncology - West Texas · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Hendrick Medical Center ( Site 0117) · Merck Sharp & Dohme LLC · NCT06393374 Evaluation of the Bexa Breast Examination
NA · Hendrick Health - Vera West Women's Center · Sure, Inc. · NCT06643767 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · Texas Oncology - Abilene - Antilley Road /ID# 265820 · AbbVie · NCT06109272 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Retina Research Institute of Texas · Astellas Pharma Global Development, Inc. · NCT06779773 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Texas Oncology - West Texas · Pfizer · NCT07144280 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0378 · Celgene · NCT05519085 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Texas Oncology - West Texas · Bristol-Myers Squibb · NCT06561386 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · Retina Research Institute of Texas · Kodiak Sciences Inc · NCT06990399 SELUTION 4 De Novo Small Vessel IDE Trial
NA · Hendrick Health · M.A. Med Alliance S.A. · NCT05946629 Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geog
Phase 1/Phase 2 · Retina Research Institute of Texas /ID# 262141 · AbbVie · NCT07160179 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Texas Oncology - West Texas · Pfizer · NCT07222800 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Hendrick Medical Center · NRG Oncology · NCT04852887 A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Phase 2 · Abilene, Texas · EyeBiotech Ltd. · NCT07205887 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Hendrick Medical Center · National Cancer Institute (NCI) · NCT05564377 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Local Institution - 007-554B · Mirati Therapeutics Inc. · NCT04613596 Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Phase 3 · Hendrick Medical Center · Alliance for Clinical Trials in Oncology · NCT05008848 A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 3 · Hendrick Medical Center ( Site 0009) · Merck Sharp & Dohme LLC · NCT06966700 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Hendrick Medical Center · National Cancer Institute (NCI) · NCT04267848 Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Phase 2 · Texas Oncology · Taiho Oncology, Inc. · NCT05727176 Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harbor
Phase 3 · Hendrick Health · Boehringer Ingelheim · NCT07195695 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Hendrick Medical Center · SWOG Cancer Research Network · NCT03851445 A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Pa
Phase 3 · Texas Oncology, P.A. - Abilene - 300210366 · EMD Serono Research & Development Institute, Inc. · NCT07549412 Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cel
Phase 3 · Hendrick Health System · Gilead Sciences · NCT06801834 A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirv
Phase 2 · Texas Oncology - Abilene - Antilley Road /ID# 277739 · AbbVie · NCT07059845 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Abilene Ctr For Ortho and Multi · Stryker Instruments · NCT03072927 A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With D
Phase 1 · Retina Research Institute of Texas · Genentech, Inc. · NCT07425522 Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Hendrick Health System · Gilead Sciences · NCT05633654 A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Parti
Phase 3 · Texas Oncology West Texas · Janssen Research & Development, LLC · NCT06662786

Look up another city

Look up another condition